The buflomedil joint defibrase in the treatment of acute cerebral infarction thrombolytic therapy time. This study shows that: the loss of the timing of thrombolytic therapy in acute cerebral infarction patients, moncler jackor, buflomedil joint defibrase enzyme treatment is still effective, and no significant side effects, it is worth clinical application.